{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Infective endocarditis",
      "Rothia",
      "Rothia dentocariosa"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33164836",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "08",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "10",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.medmal.2020.10.021",
      "S0399-077X(20)30761-7"
    ],
    "Journal": {
      "ISSN": "2666-9919",
      "JournalIssue": {
        "Volume": "51",
        "Issue": "3",
        "PubDate": {
          "Year": "2021",
          "Month": "May"
        }
      },
      "Title": "Infectious diseases now",
      "ISOAbbreviation": "Infect Dis Now"
    },
    "ArticleTitle": "Rothia spp. infective endocarditis: A systematic literature review.",
    "Pagination": {
      "StartPage": "228",
      "EndPage": "235",
      "MedlinePgn": "228-235"
    },
    "Abstract": {
      "AbstractText": [
        "To describe the epidemiological, clinical, microbiological, and therapeutic features and outcomes of Rothia infective endocarditis (RIE) and extracardiac infections (ECRI).",
        "We performed a systematic literature review of published cases of RIE and ECRI.",
        "After inclusion of a personal case report, 51 cases of RIE and 215 cases of ECRI were reported. Compared with ECRI patients, RIE patients were significantly more often males (80% versus 59%), intravenous drug users (IVDU) (20% versus 3%), immunocompetent (76% versus 31%), and infected with R. dentocariosa (55% versus 13%) but lacked significant differences with regard to median age (45 years [6-79]), rate of orodental abnormalities (33%), and six-month mortality (14%). Following microbiological documentation, RIE was most often treated with a beta-lactam antibiotic alone (39%) for a median duration of six weeks and required surgery in 39% of cases.",
        "RIE is rare and likely secondary to a dental portal of entry or cutaneous inoculation in IVDU. Its prognosis seems to be favorable."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Masson SAS. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Infectious and Tropical Diseases, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France."
          }
        ],
        "LastName": "Franconieri",
        "ForeName": "F",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Microbiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France; Research Group on Microbial Adaptation, Normandie Univ, UNICAEN, EA2656, GRAM 2.0, 14000 Caen, France."
          }
        ],
        "LastName": "Join-Lambert",
        "ForeName": "O",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biostatistics and Clinical Research Unit, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France."
          }
        ],
        "LastName": "Creveuil",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Microbiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France."
          }
        ],
        "LastName": "Auzou",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France."
          }
        ],
        "LastName": "Labombarda",
        "ForeName": "F",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France."
          }
        ],
        "LastName": "Aouba",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Infectious and Tropical Diseases, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France; Research Group on Microbial Adaptation, Normandie Univ, UNICAEN, EA2656, GRAM 2.0, 14000 Caen, France."
          }
        ],
        "LastName": "Verdon",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Infectious and Tropical Diseases, Normandie Univ, UNICAEN, CHU de Caen Normandie, 14000 Caen, France. Electronic address: delablanchardiere-a@chu-caen.fr."
          }
        ],
        "LastName": "de La Blanchardi\u00e8re",
        "ForeName": "A",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Systematic Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Infect Dis Now",
    "NlmUniqueID": "101775152",
    "ISSNLinking": "2666-9919"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "beta-Lactams"
    }
  ],
  "SupplMeshList": [
    "Rothia dentocariosa"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Cardiac Surgical Procedures"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Echocardiography"
    },
    {
      "QualifierName": [
        "epidemiology",
        "microbiology",
        "therapy"
      ],
      "DescriptorName": "Endocarditis"
    },
    {
      "QualifierName": [
        "epidemiology",
        "microbiology",
        "therapy"
      ],
      "DescriptorName": "Endocarditis, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Micrococcaceae"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "beta-Lactams"
    }
  ]
}